These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28322151)

  • 1. Editorial: New Therapeutic Approaches for the Treatment of Glioblastoma.
    Festuccia C; Gravina GL
    Curr Cancer Drug Targets; 2017; 17(3):200-202. PubMed ID: 28322151
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma.
    Shen J; Hodges TR; Song R; Gong Y; Calin GA; Heimberger AB; Zhao H
    Mol Carcinog; 2018 Jan; 57(1):137-141. PubMed ID: 28926136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the Effects of MicroRNA-221 Expression Levels in Glioblastoma Multiforme Tumors.
    Ozdogan S; Yaltirik CK; Yilmaz SG; Akdeniz FT; Sumerkent K; Duzkalir AH; Ture U; Isbir T
    Anticancer Res; 2020 Jun; 40(6):3265-3270. PubMed ID: 32487621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age.
    Ferris SP; Goode B; Joseph NM; Kline CN; Samuel D; Gupta N; Bollen A; Perry A; Mueller S; Solomon DA
    Acta Neuropathol; 2016 Jul; 132(1):153-5. PubMed ID: 27161253
    [No Abstract]   [Full Text] [Related]  

  • 5. No association of MDM2 SNP309 with risk of glioblastoma and prognosis.
    El Hallani S; Marie Y; Idbaih A; Rodero M; Boisselier B; Laigle-Donadey F; Ducray F; Delattre JY; Sanson M
    J Neurooncol; 2007 Dec; 85(3):241-4. PubMed ID: 17568997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI study identifies three subtypes of glioblastoma.
    Brower V
    Lancet Oncol; 2015 Oct; 16(13):e484. PubMed ID: 26365415
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients.
    Carlsson A; Persson O; Ingvarsson J; Widegren B; Salford L; Borrebaeck CA; Wingren C
    Proteomics Clin Appl; 2010 Jul; 4(6-7):591-602. PubMed ID: 21137077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
    Kesari S
    Semin Oncol; 2011 Dec; 38 Suppl 4():S2-10. PubMed ID: 22078644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomics illuminates a deadly brain cancer.
    Kuehn BM
    JAMA; 2010 Mar; 303(10):925-7. PubMed ID: 20215599
    [No Abstract]   [Full Text] [Related]  

  • 10. Extrachromosomal DNA: Redefining the pathogenesis of glioblastoma.
    Shiras A; Mondal A
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188551. PubMed ID: 33892052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuro-oncology: a step towards clinical blood biomarkers of glioblastoma.
    Preusser M
    Nat Rev Neurol; 2014 Dec; 10(12):681-2. PubMed ID: 25366110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?
    Lester A; Rapkins R; Nixdorf S; Khasraw M; McDonald K
    Clin Transl Oncol; 2017 Mar; 19(3):273-278. PubMed ID: 27655368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult Glioblastoma.
    Alexander BM; Cloughesy TF
    J Clin Oncol; 2017 Jul; 35(21):2402-2409. PubMed ID: 28640706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional validation confirms genomic phenotypes of glioblastoma with implications for targeted therapy.
    Parsa AT
    World Neurosurg; 2011; 75(5-6):573-4. PubMed ID: 21704908
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonal diversity in glioblastoma: is it clinically relevant?
    Watts C; Piccirillo SG
    Future Oncol; 2015; 11(12):1703-6. PubMed ID: 26075436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.
    Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL
    J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
    Tanwar MK; Gilbert MR; Holland EC
    Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Concomitant Radiochemotherapy on Invasion Potential of Glioblastoma.
    Hutóczki G; Bognár L; Tóth J; Scholtz B; Zahuczky G; Hanzély Z; Csősz É; Reményi-Puskár J; Kalló G; Hortobágyi T; Klekner A
    Pathol Oncol Res; 2016 Jan; 22(1):155-60. PubMed ID: 26450124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.